Screenshot of Trulieve’s website
One of Florida’s top medical marijuana companies faces a proposed securities class action claiming it misled investors since going public in 2018.
The federal lawsuit filed Monday by Phillip Kim of The Rosen Law Firm in New York said Trulieve Cannabis Corp. deceived its investors about its marijuana-growing procedures, hid insider involvement in real estate deals and overstated corporate profits.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
